Lp-PLA2, also known as Lipoprotein-associated Phospholipase A2 or platelet-activating factor acetylhydrolase (PAF-AH), is an enzyme produced by inflammatory cells that functions to inactivate and degrade platelet-activating factor, a potent pro-inflammatory phospholipid, while also being responsible for hydrolyzing oxidatively modified polyunsaturated fatty acids. The products of the enzymatic actions of Lp-PLA2 have been linked to the development of atherosclerosis, and are positively correlated with increased risk of coronary heart disease and stroke. This marker has recently been studied as a therapeutic target for cardiac diseases.
CLONE:
IHC407
ISOTYPE:
HOST SPECIES:
Mouse
CLONALITY:
Monoclonal
POSITIVE CONTROL:
Tonsil, Thymus, Placenta
DILUTION RANGE:
INTENDED USE/REG. STATUS:
IVD